UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Learn What Budgeting Errors Are Typical For People and how small changes can significantly improve financial health.
19,250 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
As data centers expand and AI workloads surge, a handful of tech leaders stand out as potential monster stocks hold n...
Unlock the essentials of the earn 2025 earnings transcript. This plain‑speak guide breaks down what to listen for, ho...
SpaceX is poised to make a historic move into public markets. This guide breaks down what retail investors should kno...
Two Disney-inspired retirement paths collide as investors weigh Celebration, Florida and Cotino in Rancho Mirage. Thi...
In Part 10 of Millionaire Wisdom, we unpack repeatable habits, smart investing, and risk management that help build r...
As KVHI gears up for the 2025 earnings call, investors should focus on revenue drivers, margins, and long-term strate...
A swift flow of inflation signals can reshape markets. This guide explains what to watch, how inflation could unfold,...
After years of headwinds, Target is showing early signs of life. Yet the stock price tells a story of cautious optimi...
Ticket prices for concerts and major sports events are rising in 2026. This report explains the forces behind behind ...
SpaceX sits on a colossal cash hoard, but does $100 billion guarantee long-term growth? This guide breaks down what t...
A great-looking loan deal can hide serious risks. Discover seven red flags and proven strategies to protect your mone...